Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 729 JPY 0.26% Market Closed
Market Cap: 425.9B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Kobayashi Pharmaceutical Co Ltd stock under the Base Case scenario is 6 884.48 JPY. Compared to the current market price of 5 729 JPY, Kobayashi Pharmaceutical Co Ltd is Undervalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6 884.48 JPY
Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Kobayashi Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Kobayashi Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Kobayashi Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Kobayashi Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Kobayashi Pharmaceutical Co Ltd.

What unique competitive advantages
does Kobayashi Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Kobayashi Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kobayashi Pharmaceutical Co Ltd.

Provide P/S
for Kobayashi Pharmaceutical Co Ltd.

Provide P/E
for Kobayashi Pharmaceutical Co Ltd.

Provide P/OCF
for Kobayashi Pharmaceutical Co Ltd.

Provide P/FCFE
for Kobayashi Pharmaceutical Co Ltd.

Provide P/B
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/S
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/GP
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/EBIT
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/OCF
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/FCFF
for Kobayashi Pharmaceutical Co Ltd.

Provide EV/IC
for Kobayashi Pharmaceutical Co Ltd.

Show me price targets
for Kobayashi Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Kobayashi Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Kobayashi Pharmaceutical Co Ltd?

What are the Net Income projections
for Kobayashi Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Kobayashi Pharmaceutical Co Ltd?

What are the EPS projections
for Kobayashi Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Kobayashi Pharmaceutical Co Ltd?

What are the EBIT projections
for Kobayashi Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Kobayashi Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Kobayashi Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kobayashi Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kobayashi Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kobayashi Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Kobayashi Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Kobayashi Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Kobayashi Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Kobayashi Pharmaceutical Co Ltd.

Provide ROE
for Kobayashi Pharmaceutical Co Ltd.

Provide ROA
for Kobayashi Pharmaceutical Co Ltd.

Provide ROIC
for Kobayashi Pharmaceutical Co Ltd.

Provide ROCE
for Kobayashi Pharmaceutical Co Ltd.

Provide Gross Margin
for Kobayashi Pharmaceutical Co Ltd.

Provide Operating Margin
for Kobayashi Pharmaceutical Co Ltd.

Provide Net Margin
for Kobayashi Pharmaceutical Co Ltd.

Provide FCF Margin
for Kobayashi Pharmaceutical Co Ltd.

Show all solvency ratios
for Kobayashi Pharmaceutical Co Ltd.

Provide D/E Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide D/A Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide Quick Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide Current Ratio
for Kobayashi Pharmaceutical Co Ltd.

Provide Cash Ratio
for Kobayashi Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Kobayashi Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Kobayashi Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Kobayashi Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kobayashi Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kobayashi Pharmaceutical Co Ltd

Current Assets 132.3B
Cash & Short-Term Investments 60.4B
Receivables 35.1B
Other Current Assets 36.9B
Non-Current Assets 129.9B
Long-Term Investments 35.9B
PP&E 65.8B
Intangibles 22.5B
Other Non-Current Assets 5.7B
Current Liabilities 45.9B
Accounts Payable 15.1B
Accrued Liabilities 2.9B
Other Current Liabilities 28B
Non-Current Liabilities 6.6B
Long-Term Debt 721m
Other Non-Current Liabilities 5.9B
Efficiency

Earnings Waterfall
Kobayashi Pharmaceutical Co Ltd

Revenue
173B JPY
Cost of Revenue
-78.3B JPY
Gross Profit
94.6B JPY
Operating Expenses
-69.8B JPY
Operating Income
24.8B JPY
Other Expenses
-10.9B JPY
Net Income
13.9B JPY

Free Cash Flow Analysis
Kobayashi Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kobayashi Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Year Average ROIC
Positive Operating Income
55/100
Profitability
Score

Kobayashi Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kobayashi Pharmaceutical Co Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Kobayashi Pharmaceutical Co Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kobayashi Pharmaceutical Co Ltd

Wall Street analysts forecast Kobayashi Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kobayashi Pharmaceutical Co Ltd is 5 922.38 JPY with a low forecast of 4 949 JPY and a high forecast of 7 350 JPY.

Lowest
Price Target
4 949 JPY
14% Downside
Average
Price Target
5 922.38 JPY
3% Upside
Highest
Price Target
7 350 JPY
28% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Kobayashi Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kobayashi Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd

Country

Japan

Industry

Consumer products

Market Cap

425.9B JPY

Dividend Yield

1.76%

Description

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Contact

OSAKA-FU
Osaka
KDX Kobayashi Doshomachi Bldg., 4-4-10, Dosho-machi, Chuo-ku
+81662311144.0
www.kobayashi.co.jp

IPO

1999-04-20

Employees

3 451

Officers

President, Senior MD, Exec. Officer & Head of Sustainability Management Headquarters and Director
Mr. Satoshi Yamane
Executive Officer & CFO Unit Head
Ms. Yumi Nakagawa
Executive Officer & Head of Sales Headquarters
Kenji Kobori
General Manager of General Affairs Department & Human Resources Dept
Takayuki Kimura
Managing Executive Officer & GM of Healthcare Division
Mr. Fujito Ohwaki
Executive Officer & CDO Unit Head
Mr. Ryo Ishido
Show More
Executive Officer & Head of Manufacturing Headquarters
Kenji Yamashita
Executive Officer & Head of Compensation Division
Kei Sato
Manager of Investor Relations
Kazuki Kuriyama
Investor Relations Executive
Yusuke Tatsumi
Show Less

See Also

Discover More
What is the Intrinsic Value of one Kobayashi Pharmaceutical Co Ltd stock?

The intrinsic value of one Kobayashi Pharmaceutical Co Ltd stock under the Base Case scenario is 6 884.48 JPY.

Is Kobayashi Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5 729 JPY, Kobayashi Pharmaceutical Co Ltd is Undervalued by 17%.

Back to Top